Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Mosquito-borne diseases and control, and Viral Infections and Vectors.
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort.
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Viral evolution sustains a dengue outbreak of enhanced severity.
Genomic Epidemiology of 2015–2016 Zika Virus Outbreak in Cape Verde
Novel genome sequences of cell-fusing agent virus allow comparison of virus phylogeny with the genetic structure of <i>Aedes aegypti</i> populations.
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Autochthonous Japanese Encephalitis with Yellow Fever Coinfection in Africa